ADAM17 and Alzheimer disease: A previous study has found that a loss-of-function genetic variant in ADAM17 is associated with the pathogenesis of AD in humans (Hartl et al., 2020), whereas in rodent models genetic ADAM17 deletion caused an impaired collateral circulation formation and vascular growth in the cerebral surface arterioles (Lucitti et al., 2012).